18 Aug, 2023 Advancing Healthcare: Unveiling the potential Latin American and Caribbean Medicines Agency By Bruna Rocha Carolina Caiado Juliana Marcondes Victoria Cristofaro +1 more... Show less Currently it is widely known that the Latin American markets operate with their respective regulatory health bodies, varying from having...
19 May, 2023 Brazilian Health Regulatory Agency updates regulation that governs requirements for clinical laboratory tests By Bruna Rocha Juliana Marcondes Victoria Cristofaro On May 3rd of this year, Anvisa approved Resolution No. 786/2023 ("RDC 786/2023"), which addresses the technical and health requirements...
19 Jan, 2023 What is the projected – and much anticipated – key pillar for the health sector in Brazil in 2023? By Bruna Rocha Juliana Marcondes Victoria Cristofaro During the World Economic Forum 2023 in Davos, specialists discussing the topic of health unanimously indicated that “the past three...
10 Nov, 2022 SPACs targeting Latin America-based life sciences and healthtech companies By Bruna Rocha Juliana Marcondes The SPAC structure not only enables the target companies to be listed in the United States’ public stock market through a simpler and...
17 May, 2022 Digital Health Transformation: The new Brazilian law on digital drugs leaflets By Bruna Rocha Juliana Marcondes Victoria Cristofaro Yesterday morning (12), the Brazilian Federal Government approved Law n. 14,338/22, which results from a bill of the Chamber of Deputies...
14 Mar, 2022 Breaking taboos: the ascension of FemTechs in the healthcare market By Bruna Rocha Victoria Cristofaro International Women's Day, celebrated every March 8, focuses on the achievements of women over the years in the cultural, political and...